Upcoming CLIAC Meeting
General information and meeting topics are published at least 15 calendar days in advance in the Federal Register, with detailed agendas posted prior to the meeting. Meetings are open to the public and are also webcast.
Please visit this page prior to and during the meeting to access information as it becomes available, such as updated agendas, presentations, and handouts. Public comments can also be submitted in advance of the meeting for consideration by the Committee.
The meeting will be held virtually on April 14, 2021, 11:00 a.m. to 6:00 p.m., EDT and April 15, 2021, 11:00 a.m. to 6:00 p.m., EDT. The agenda will include agency updates from CDC, CMS, and FDA. In addition to the agency updates, presentations will include an update on CLIAC recommendations and an overview of the Laboratory Response Network. The focus of the meeting is a continuation of the fall 2020 theme, Clinical Laboratory Medicine in the Age of COVID-19 and will include presentations and discussions on clinical laboratory perspectives on laboratory-developed tests; application of CLIA regulations during the COVID-19 pandemic; and the expansion of point-of-care and at-home collection and testing. Agenda items are subject to change as priorities dictate.
Documents for the April 14-15, 2021 CLIAC meeting will be posted as they become available.
It is the policy of CLIAC to accept written public comments and provide a brief period for oral public comments pertinent to agenda items. Public comment periods for each agenda item are scheduled immediately prior to the Committee discussion period for that item.
How to Provide Oral Comments
In general, each individual or group requesting to present an oral comment will be limited to a total time of five minutes (unless otherwise indicated). If you want to make an oral comment during the meeting, email CLIAC@cdc.gov at least five business days prior to the meeting date. All comments will be included in the meeting Summary Report posted on this website.
How to Provide Written Comments
For individuals or groups unable to attend the meeting, CLIAC accepts written comments up to the first day of the meeting. However, it is requested that comments be submitted at least five business days prior to the meeting date so that the comments are available to the Committee for their consideration and public distribution on the CLIAC website. Email comments to CLIAC@cdc.gov or mail comments to the address below. Written comments will be included in the meeting Summary Report posted on this website.
Attention: CLIAC Secretariat
1600 Clifton Road NE
Atlanta, GA 30333